GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Trade Payables History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Trade Payables | ₹3,744 Cr | ₹3,051 Cr | ₹2,536 Cr | ₹2,000 Cr | ₹2,289 Cr |
What is the latest Trade Payables ratio of GLENMARK PHARMACEUTICALS ?
| Year | Trade Payables |
|---|---|
| Mar2026 | ₹3,744 Cr |
| Mar2025 | ₹3,051 Cr |
| Mar2024 | ₹2,536 Cr |
| Mar2023 | ₹2,000 Cr |
| Mar2022 | ₹2,289 Cr |
How is Trade Payables of GLENMARK PHARMACEUTICALS Trending?
| Years | Trade Payables | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,744 Cr | 22.70 | |
| Mar2025 | ₹3,051 Cr | 20.32 | |
| Mar2024 | ₹2,536 Cr | 26.77 | |
| Mar2023 | ₹2,000 Cr | -12.59 | |
| Mar2022 | ₹2,289 Cr | - | |
Compare Trade Payables of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹69,910.8 Cr | -0.1% | 7.7% | 26.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,339.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,068.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,767.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹111,804.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,113.4 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.1% |
7.7% |
26.5% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses